July 03, 2023
An Arizona federal judge has decided that a license agreement Bard signed with a medical device company that sells vascular stents can't be enforced after the patent's expiration date, labeling Bard's $52.8 million lawsuit against the company a clear case of "patent misuse."
March 24, 2023
An Arizona federal judge has cleared medical manufacturer C.R. Bard of counterclaims including unjust enrichment in its $27 million contract breach suit against a licensee over surgical patents, but held that he can't yet determine whether the licensee violated a royalties provision.